Geneva Partners LLC Takes $2.54 Million Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Geneva Partners LLC acquired a new stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 38,217 shares of the company's stock, valued at approximately $2,537,000. Ryan Specialty comprises approximately 1.1% of Geneva Partners LLC's portfolio, making the stock its 29th largest holding.

Other large investors have also made changes to their positions in the company. GAMMA Investing LLC lifted its position in Ryan Specialty by 96.4% during the second quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after buying an additional 297 shares during the period. Crewe Advisors LLC purchased a new position in Ryan Specialty during the second quarter worth about $39,000. Signaturefd LLC lifted its position in Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company's stock worth $89,000 after buying an additional 148 shares during the period. Rothschild Investment LLC purchased a new position in shares of Ryan Specialty in the 2nd quarter worth about $87,000. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in shares of Ryan Specialty by 1,688.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,844 shares of the company's stock worth $165,000 after purchasing an additional 2,685 shares during the period. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Stock Performance

Shares of NYSE RYAN traded up $1.64 during mid-day trading on Tuesday, hitting $69.21. The company had a trading volume of 809,172 shares, compared to its average volume of 880,136. The stock has a market cap of $18.09 billion, a price-to-earnings ratio of 89.87, a PEG ratio of 1.50 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $73.10. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm's 50 day simple moving average is $67.11 and its two-hundred day simple moving average is $60.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. The business had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business's revenue was up 20.5% on a year-over-year basis. During the same quarter last year, the business posted $0.32 EPS. As a group, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be issued a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Tuesday, November 12th. Ryan Specialty's dividend payout ratio (DPR) is 57.14%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on RYAN shares. Citigroup raised their price objective on Ryan Specialty from $56.00 to $62.00 and gave the stock a "neutral" rating in a report on Tuesday, July 23rd. BMO Capital Markets upgraded Ryan Specialty from a "market perform" rating to an "outperform" rating and raised their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. Barclays began coverage on Ryan Specialty in a report on Wednesday, September 4th. They set an "overweight" rating and a $76.00 target price on the stock. UBS Group raised their price objective on Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research note on Tuesday, August 13th. Finally, Bank of America raised their price objective on Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $70.33.

Insider Buying and Selling

In other Ryan Specialty news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of Ryan Specialty stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the sale, the executive vice president now owns 24,845 shares of the company's stock, valued at $1,619,397.10. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Ryan Specialty news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of Ryan Specialty stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the sale, the executive vice president now owns 24,845 shares of the company's stock, valued at $1,619,397.10. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nicholas Dominic Cortezi sold 1,500 shares of Ryan Specialty stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $65.02, for a total value of $97,530.00. Following the sale, the director now directly owns 25,123 shares in the company, valued at $1,633,497.46. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,107,136 shares of company stock valued at $131,860,032. Insiders own 11.10% of the company's stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.